Avanos Medical, Inc.

AVNS - Financial Snapshot

Metrics for AVNS

Price $13.42
Shares Outstanding 46.42M
All-Time Low $9.30
52-Week Low $9.30

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $1.33
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $5.64
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual) -1.58%
Shares Δ YoY -0.46%

Income Metrics

Max Earning Power / Share $2.05
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-0.29
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 1.52%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 02-03-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 2-1-2026
Income indicators Value Date
EBITDA Positive Yes 2-1-2026
Net Income Positive No 2-1-2026
Avg CA Burn (Annual %) 1.59% 2-1-2026
Avg CA Burn (Quarterly %) -6.86% 2-1-2026

Shares Outstanding Changes

Date Shares Outstanding Delta
2025-11-07 46,418,907 +16,426
2025-09-17 46,402,481 -19
2025-08-06 46,402,500 +158,500

Short Interest Changes

Latest short interest: 3,218,424 shares (9.82% of float) | Days to cover: 5.76

Date Short Interest Delta Δ %
2026-02-03 3,218,424 shares +0 +0.00%
2026-02-02 3,218,424 shares +0 +0.00%
2026-01-30 3,218,424 shares None

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.